MEDP: Medpace Holdings, Inc. Stock

by  •  • Comments Off on MEDP: Medpace Holdings, Inc. Stock

SIC 8731 – Commercial Physical and Biological Research

Valuation
Market Cap ($M) 12,289.90
Enterprise Value ($M) 11,882.89
Book Value ($M) 671.54
Book Value / Share 21.72
Price / Book 18.30
NCAV ($M) -379.35
NCAV / Share -12.27
Price / NCAV -32.40

Profitability (mra)
Return on Invested Capital (ROIC) 0.38
Return on Assets (ROA) 0.22
Return on Equity (ROE) 0.90

Liquidity (mrq)
Quick Ratio 0.78
Current Ratio 0.78

Balance Sheet (mrq) ($M)
Current Assets 744.90
Assets 1,795.79
Liabilities 1,124.25
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,885.84
Operating Income 336.82
Net Income 282.81
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 433.37
Cash from Investing -34.63
Cash from Financing -182.64

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-08 13D/A Troendle August J. 19.40 -6.54
02-13 13G/A Vanguard Group Inc 8.33 -5.18
02-09 13G/A Wasatch Advisors Inc
01-26 13G/A BlackRock Inc. 7.90 -23.55

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-23 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-10-24 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-07-25 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-25 54,179 274,804 19.72
2024-04-24 79,730 157,226 50.71
2024-04-23 210,924 235,949 89.39
2024-04-22 61,782 110,811 55.75

(click for more detail)

Similar Companies
ABSI – Absci Corporation ICLR – ICON Public Limited Company
INCY – Incyte Corporation MXCT – MaxCyte, Inc.
NRC – National Research Corporation


Financial data and stock pages provided by
Fintel.io